Myriad Genetics

Yahoo Finance • 2 days ago

Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling... Full story

Yahoo Finance • 4 days ago

Breast Cancer Awareness Month: Patient and Clinician Share Insights on how to tackle the fear of cancer screenings on YourUpdateTV

Data Shows Misconceptions Fuel Cancer Fears but Genetic Testing Can Help New Myriad Genetics Cancer Risk Survey shows that more than half of women at high-risk for hereditary cancer would feel "empowered" by more advanced screening like g... Full story

Yahoo Finance • last month

Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology

SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced The Lancet Oncology published a study highlighting the performance... Full story

Yahoo Finance • last month

New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression

SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six prospective controll... Full story

Yahoo Finance • last month

Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others

Company Logo Liquid Biopsy MarketLiquid Biopsy Market Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Market by Product & Service (Kits, Instruments), Circulating Biomarker (ctDNA, cfDNA, CTC), Technology (NGS, PCR), Applic... Full story

Yahoo Finance • last month

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

SALT LAKE CITY, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare confer... Full story

Yahoo Finance • 2 months ago

ANGLE plc partners with Myriad Genetics to advance cancer diagnostics

[Diagnosis testing of patients.] Natali_Mis/iStock via Getty Images ANGLE plc (OTCQX:ANPCF [https://seekingalpha.com/symbol/ANPCF]) and Myriad Genetics (NASDAQ:MYGN [https://seekingalpha.com/symbol/MYGN]) have announced a new partnership... Full story

Yahoo Finance • 2 months ago

Myriad Genetics announces CFO appointment

* Ben Wheeler appointed chief financial officer of Myriad Genetics (NASDAQ:MYGN [https://seekingalpha.com/symbol/MYGN]), effective August 16, 2025. * Wheeler has been with the company since 2011, most recently serving as CFO of Operat... Full story

Yahoo Finance • 2 months ago

Myriad Genetics Appoints Ben Wheeler Chief Financial Officer

SALT LAKE CITY, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Ben Wheeler has been promoted to Chief Financial Officer, effe... Full story

Yahoo Finance • 2 months ago

New Myriad Genetics Survey Uncovers Women Fear Screenings—But Feel Reassured by the Results

SALT LAKE CITY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today released findings from its latest Cancer Risk Survey that uncover a striking... Full story

Yahoo Finance • 2 months ago

What's going on in today's session

Curious about what's happening in today's session? Check out the latest stock movements and price changes. [topmovers] TOP GAINERS TICKER CHANGE COMMENT SGBX [https://www.chartmill.com/stock/quote/SGBX/profile] 86.14% SAF... Full story

Yahoo Finance • 2 months ago

Here are the top movers in Wednesday's session.

Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis. [topmovers] TOP GAINERS TICKER CHANGE COMMENT GO [https://www.cha... Full story

Yahoo Finance • 2 months ago

The market is filled with gapping stocks in Wednesday's session.

Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps. [gap] GAP UP STOCKS TICKER CHANGE COMMENT SGBX [https://www.chartmill.com/stock/quote/SGBX... Full story

Yahoo Finance • 2 months ago

Discover the top movers in Wednesday's pre-market session.

As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. [premarket] TODAY'S PRE-MARKET GAINERS TICKER CHANGE COMME... Full story

Yahoo Finance • 2 months ago

Myriad Genetics outlines high single-digit to low double-digit growth target through cancer care continuum focus

Earnings Call Insights: Myriad Genetics (MYGN) Q2 2025 MANAGEMENT VIEW * President and CEO Samraat S. Raha opened by stating he remains confident in Myriad's significant potential, emphasizing, "I'm excited about the journey we're on t... Full story

Yahoo Finance • 2 months ago

Myriad Genetics (MYGN) Q2 Revenue Up 6%

Key Points Revenue (GAAP) exceeded analyst estimates by 5.6%, with strong pricing and product mix lifting the topline. Reported a non-cash impairment charge of $316.7 million (GAAP), leading to a large net loss despite adjusted EPS of $0.... Full story

Yahoo Finance • 2 months ago

Top movers in Tuesday's after hours session

The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. [postmarket] GAINERS TICKER CHANGE COMMENT... Full story

Yahoo Finance • 2 months ago

Myriad Genetics Q2 2025 slides: revenue growth accelerates, guidance raised

Myriad Genetics Inc (NASDAQ:MYGN) presented its second quarter 2025 earnings results on August 5, showing signs of recovery after a challenging first quarter. The genetic testing company reported modest revenue growth and raised its full-... Full story

Yahoo Finance • 2 months ago

Myriad genetics announces new $200 million credit facility

* Myriad Genetics (NASDAQ:MYGN [https://seekingalpha.com/symbol/MYGN]) announced on Thursday it has closed a five-year senior secured term loan credit facility providing up to $200 million of capital from OrbiMed. * The facility includ... Full story

Yahoo Finance • 2 months ago

Myriad Genetics to Release Second Quarter 2025 Financial Results on August 5, 2025

SALT LAKE CITY, July 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its second quarter 2025 earnings conference call at 4:30pm ET on Tuesday,... Full story